About Celarix
Celarix, founded in 1998 in Cambridge, United States. Limited information available Led by John Doe as CEO. The company is dedicated to excellence, innovation, and customer satisfaction in its operations. It continues to evolve, meeting industry challenges with strategic approaches and commitment to quality.
- Headquarter Cambridge, United States
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$17 M (USD), Debt – Convertible
Jan 09, 2002
-
Investors
J P Morgan
& 5 more
-
Employee Count
Not available
-
Acquired by
GXS
(Jun 04, 2003)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Celarix
Investors in Celarix
Celarix has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include J P Morgan, GXS and Austin Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in Texas-based companies.
|
Locked | Locked | Locked | |
|
Early-stage companies are invested in globally by TL Ventures.
|
Locked | Locked | Locked | |
|
Growth stage tech & life sciences focused VC firm funding companies in the US
|
Locked | Locked | Locked |
Investor details for Celarix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Celarix
Investment portfolio details for Celarix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Celarix
Detailed financials for Celarix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Celarix Comparisons
Peer comparison for Celarix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Celarix
Detailed competitors of Celarix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Celarix
Complete news archive for Celarix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Celarix
Celarix was founded in 1998 and raised its 1st funding round 4 years after it was founded.
Celarix is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
John Doe is the current CEO of Celarix.
Celarix, founded in 1998 in Cambridge, United States. Limited information available Led by John Doe as CEO. The company is dedicated to excellence, innovation, and customer satisfaction in its operations. It continues to evolve, meeting industry challenges with strategic approaches and commitment to quality.
Celarix has 6 investors. Key investors include J P Morgan, GXS, Austin Ventures, TL Ventures, and Integral Capital Partners.